Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Buy” from Analysts

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock in the […]

Leave a Reply

Your email address will not be published.

Previous post Glacier Bancorp, Inc. (NASDAQ:GBCI) Given Average Recommendation of “Moderate Buy” by Brokerages
Next post Analyzing Globalstar (NYSE:GSAT) & Gogo (NASDAQ:GOGO)